Evidence map›Paper›PMID 28392828›Full record

ArticleAnnals of general psychiatry2017

Screening of Wilson's disease in a psychiatric population: difficulties and pitfalls. A preliminary study.

Caroline Demily, François Parant, David Cheillan, Emmanuel Broussolle, Alice Pavec, Olivier Guillaud, Lioara Restier, MOPSY Consortium, Alain Lachaux, Muriel Bost

Open access · goldAbstract read
In one paragraph

Article in Annals of general psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Caroline DemilyGénoPsy, Center for the Detection and Management of Psychiatric Disorders of Genetic Origin, Pôle Ouest, Hôpital le Vinatier & UMR 5229 (CNRS & Lyon University), 95 Bld Pinel, 69677 Bron cedex, France.
François ParantPharmaco-Toxicology, Biochemistry and Molecular Biology Unit, Hôpital Édouard Herriot, Hospices Civils de Lyon, Lyon, France.
David CheillanLaboratory of Inherited Metabolic Diseases, Centre de Biologie Est, Hospices Civils de Lyon, Bron, France.
Emmanuel BroussolleNational Reference Center for Wilson's disease, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France.
Alice PavecHôpital Saint Jean de Dieu, Lyon, France.
Olivier GuillaudNational Reference Center for Wilson's disease, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France.
Lioara RestierNational Reference Center for Wilson's disease, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France.
MOPSY Consortium
Alain LachauxNational Reference Center for Wilson's disease, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France.
Muriel BostLaboratory of Inherited Metabolic Diseases, Centre de Biologie Est, Hospices Civils de Lyon, Bron, France.
Hôpital Femme Mère Enfant · FRHospices Civils de Lyon · FRCentre Hospitalier de Saint Jean de Dieu · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWilson's disease (WD) is a rare autosomal-recessive, inherited disorder caused by a mutation in the copper-transporting gene

methodsAll psychiatric patients who participated in this study were hospitalized in Saint-Jean de Dieu Hospital (Lyon, France). Cp was measured by immunoturbidimetry and serum Cu by inductively coupled plasma-optical emission spectrometry. When Cp and serum Cu levels were inferior to, respectively, 0.18 g/L and 0.88 mg/L in combination with atypical psychiatric presentations, complete clinical examinations were performed by multidisciplinary physicians specialized in WD. In addition, mutation detection in the

resultsA total of 269 patients completed the study. (1) 51 cases (19%) showed both decreased Cp and Cu concentrations. (2) Molecular genetic tests were performed in 29 patients, and one

conclusionResults of Cp and/or serum Cu concentrations below the normal limits are common in patients with psychiatric disorders and nonrelevant and/or informative for the WD diagnosis. WD diagnosis is based on a combination of clinical and biological arguments. Psychiatric patients with suspicion of WD should be evaluated in a reference center.

Indexed as

Alcohol abuseATP7B geneBipolar disordersCeruloplasminCopper chelatorsCopper homeostasisEtiopathogenesisInborn errors of metabolismMental diseasesMental healthPsychiatric disordersSchizophreniaSerum copperTreatable hereditary metabolic disordersWilson’s disease

Identifiers

PMID28392828
PMCPMC5379609
OpenAlexW2604441273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.